2-(2,4-Dichlorobenzyl)-1H-benzo[d]imidazole, 95.0%, 10g

(3-BROMO-6-CHLOROPYRIDIN-2-YL)METHANOL, 95.0%, 10g

Recipiente de reacción ROTILABO®, 20 ml, 1 pieza

(2S)-1-[[2,6-Dimethoxy-4-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]phenyl]methyl]-2-piperidinecarboxylic acid, 1g

2-Nitrobenzene-1,3-diol, 95.0%, 1g

3,4-diethoxy-N-methoxy-N-methylbenzamide, 95.0%, 2g

Xanthohumol, >98%, 25mg

(R)-Methyl 2-(benzylamino)-3-hydroxypropanoate, 95.0%, 5g

4-Chloropyridine-3-sulfonyl chloride, 95+%, 10g

(4S,4'S)-2,2'-(1,3-BIS(4-(TERT-BUTYL)PHENYL)PROPANE-2,2-DIYL)BIS(4-ISOPROPYL-4,5-DIHYDROOXAZOLE), 95%, 1g

Methyl 6-chloro-1H-pyrrolo[2,3-b]pyridine-3-carboxylate, 95.0%, 5g

5-Methyl-2-furaldehyde>98.0%(GC)25mL

Triisopropyl Borate>98.0%(T)25mL